Back to All Events

The Brain Webinar Series: Epilepsy

  • The Betty & John Laidlaw AC Alfred Innovation & Education Hub 75 Commercial Road 3004 Australia (map)
 

The Brain Webinar Series: Epilepsy

FREE - in person/online - 17:30-20:00 AET

Register here

Over 65 million people worldwide are living with epilepsy. Epilepsy is a neurological disorder characterised by recurrent seizures. Seizures, caused by disruption in electrical activity in the brain, can result in changes to sensation, awareness, behaviour or movement. The most common causes of epilepsy are head trauma, stroke, infection, genetics and congenital brain abnormalities. However, in approximately half of cases, the cause of the epilepsy will be unknown.

This seminar will provide an overview of the state-of-the-art treatments for epilepsy, including new medications, surgery, dietary therapy and neuromodulation. We will also highlight novel approaches under intense research, including medical technologies, artificial intelligence, and human stem cells in personalising the approach to treatment.

The inclusion of consumers in the research team, and future opportunities for consumer engagement in epilepsy research will be discussed.

SPEAKER BIOS

Clinician Researcher, Professor Patrick Kwan

Patrick is a Professor of Neurology in the Department of Neuroscience within the School of Translational Medicine. and Co-Director of Monash Institute of Medical Engineering, a unique cross-faculty platform that provides support in the training, research and commercialisation of techno-logical solutions for unmet clinical needs.

Check out our podcast with Patrick, here.

Clinician Researcher, Dr Neha Kaul

Neha is an early-career, clinician-researcher specialising in neurosciences and critical care nutrition. She established and leads the dietary therapy for epilepsy program at Alfred Health.

Lived experience community member, Chris Ewart

Chris is one of Monash's Persons With lived Experience of Epilepsy (PWE). Given Chris' own experience with medications over the past 30 years, he is particularly interested in studies looking at the impact of epilepsy medica-tions on the lives of those taking them, including the potential side effects.

To register, click here.

Previous
Previous
8 November

2nd Advanced Course on the Pharmacological Treatment of Drug Resistant Epilepsies: From Rare to Common Epilepsies

Next
Next
8 January

Latin American Congress of Genetic Epilepsies / Congreso Latinoamericano de Epilepsias Genéticas